Physicians' Academy for Cardiovascular Education

Agenda Topics ▼Video ▼Online-CME News ▼Meeting Reports Slides ▼About

ACC.19 ▼AHA 2018 ▼Diabetes & CVD ▼EAS 2019 ▼Epigenetics in CVD ▼Expert Meeting GLP-1, CVD & T2DM ▼HFpEF: The essentials to know ▼Invest in your arteries ▼LDL-c Expert Meeting ▼LDL-c Key Messages ▼PCSK9 ▼

C-Reactive Protein, Inflammation and Atherosclerosis

Jan. 24, 2016

Share this page with your colleagues and friends:

Continue reading:

5 Things a cardiologist should know about diabetes

Slide Curriculum: Diabetes and cardiology

Slides (curriculum) - July 24, 2018

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy

Hypoglycemia in cardiovascular medicine: why worry?

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME

ACS

Benefits of dual COMPASS regimen also seen in patients with moderate renal dysfunction

Literature - May 21, 2019 - Fox KAA et al., - J Am Coll Cardiol. 2019

FDA expands indication for PCSK9 inhibitor to prevent major CV events in adults with CVD

News - May 6, 2019

Guided DAPT de-escalation therapy in PCI-treated ACS patients with diabetes vs. non-diabetes

Literature - May 1, 2019 - Hein R, et al. - EuroIntervention 2019

Atherosclerosis

2019 Anitschkow Award given for defining genetic determinants of plasma lipid levels and CV risk

News - May 27, 2019

Majority of statin-eligible US adults not taking a statin were never offered the therapy

Literature - Apr. 11, 2019 - Bradley CK et al. - J Am Heart Assoc. 2019

Direct Factor Xa inhibitor reduces coronary plaque progression in AF

Literature - Apr. 10, 2019 - Win TT et al. - Am Heart J 2019

Atrial fibrillation

No reduction in mortality and CV outcomes with catheter ablation in AF

Literature - Apr. 2, 2019 - Packer DL, et al. - JAMA 2019

Delayed cardioversion non-inferior to early cardioversion in recent-onset AF

Literature - Apr. 2, 2019 - Pluymaekers NAHA et al. - New Eng J Med 2019

Better outcomes in patients with AF and ACS/PCI with NOAC vs. VKA and when dropping aspirin

3' education - Mar. 17, 2019 - New Orleans, LA, USA - John Alexander, MD

CV Inflammation

High residual inflammatory risk associated with adverse clinical outcomes in patients undergoing PCI with low LDL-c

Literature - June 7, 2019 - Guedeney P et al. - JACC 2019

Effect of IL-1β inhibition on lung cancer sheds new light on the role of inflammation

3' education - May 28, 2019 - EAS 2019, Maastricht - Paul Ridker, MD

Childhood oral infections linked to subclinical carotid atherosclerosis in adulthood

Literature - Apr. 30, 2019 - Pussinen PJ et al. - JAMA Netw Open. 2019

CVRM

GLP-1 receptor agonist lowers MACE in broad range of persons with T2DM

News - June 11, 2019

Intensive BP lowering also seems beneficial in adults with diabetes, irrespective of baseline BP

Literature - May 20, 2019 - Rahman F et al. - Hypertension. 2019

A lot of physical activity can offset the association between sitting time and mortality risk

Literature - May 2, 2019 - Stamatakis E et al., - J Am Coll Cardiol. 2019

Diabetes

Oral GLP-1RA non-inferior to placebo in reducing major adverse cardiac events in T2DM with high CV risk

News - June 12, 2019

Comparable CV safety for DPP-4 inhibitor and sulfonylurea in T2DM patients with CVD or high CV risk

News - June 11, 2019

SGLT2 inhibitor slows progression of kidney disease and renal death in T2DM patients

News - June 11, 2019

Familial Hypercholesterolemia

Elevated Lp(a) levels and apo(a) production in response to statins

Literature - June 12, 2019 - Tsimikas S et al. - Eur Heart J 2019

Almost 1 in 10 of young adults with MI has clinically defined FH

Literature - June 6, 2019 - Singh A et al., - J Am Coll Cardiol. 2019

Failure to identify FH results in worse survival compared with people with an FH diagnosis

News - May 31, 2019

GLP-1 RA & CVD

Diabetes, Cardiology & Novel Therapeutic Approaches: Science, Outcomes and Practice

Online-CME - This course consists of 3 lectures

Treatment with GLP-1RA results in reduction of MACE in type 2 diabetes patients with established CVD

Literature - Feb. 12, 2019 - Hernandez AF et al. - The Lancet 2018

Two choices of drugs that reduce CV risk in T2DM

3' education - Feb. 7, 2019 - Prof. John Deanfield, MD

Heart Failure

Why could patients with HF and T2DM benefit from SGLT2i?

10' education - June 12, 2019 - ESC HF 2019, Athens, Greece - Prof. Subodh Verma - Toronto, ON, Canada

ARNI as first-line therapy in de novo HFrEF patients after ADHF event

3' education - June 3, 2019

Potassium binder results in more persistent use of spironolactone in resistant hypertension and CKD, also in a group of HF

3' education - June 3, 2019

HFpEF: The essentials to know

HFpEF: Current and future clinical approaches to manage HFpEF

10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, Germany

Slides: HFpEF: What are the most likely pathophysiological mechanisms involved in the disease

Slides (presentation) - Aug. 27, 2018 - Carolyn Lam, MD - Singapore

HFpEF: How to diagnose

10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA

Hypertension

Use of patiromer results in more patients remaining on spironolactone in resistant hypertension and CKD, with and without HF

News - May 25, 2019

Intensive BP lowering also seems beneficial in adults with diabetes, irrespective of baseline BP

Literature - May 20, 2019 - Rahman F et al. - Hypertension. 2019

Brain aminopeptidase A inhibitor reduces blood pressure in a high-risk diverse population

Literature - May 13, 2019 - Ferdinand KC et al. - Circulation 2019

Inflammation Expert Opinions

Ultime notizie sulla terapia: Un farmaco anti-infiammatorio riduce eventi cardiovascolari maggiori

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Breakthrough therapy: Anti-inflammatory drug can affect important CV outcomes

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Clinical implications of inhibiting inflammation as risk factor for progression of CVD

5' education - Aug. 27, 2017

Invest in your arteries

Estimating CV risk and treatment benefit

10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online CME

Importance of hypertension in CVD prevention

10' education - June 12, 2018 - Prof. Richard Hobbs - Oxford, UK - Online CME

The role of lipids in CVD prevention: Lessons learned about statins

10' education - June 6, 2018 - Prof. Kees Hovingh - Amsterdam, The Netherlands - Online CME

Lipids

Elevated Lp(a) levels and apo(a) production in response to statins

Literature - June 12, 2019 - Tsimikas S et al. - Eur Heart J 2019

High residual inflammatory risk associated with adverse clinical outcomes in patients undergoing PCI with low LDL-c

Literature - June 7, 2019 - Guedeney P et al. - JACC 2019

Almost 1 in 10 of young adults with MI has clinically defined FH

Literature - June 6, 2019 - Singh A et al., - J Am Coll Cardiol. 2019

Lp(a)

Elevated Lp(a) levels and apo(a) production in response to statins

Literature - June 12, 2019 - Tsimikas S et al. - Eur Heart J 2019

Debate on Lp(a) – treating high levels or not?

News - May 29, 2019

Estimation of required reduction of Lp(a) for a clinically relevant reduction of CHD risk

Literature - May 13, 2019 - Lamina C et al. - JAMA Cardiol. 2019

PCSK9

Elevated Lp(a) levels and apo(a) production in response to statins

Literature - June 12, 2019 - Tsimikas S et al. - Eur Heart J 2019

Pilot study shows sustained LDL-c reduction with PCSK9-siRNA in hoFH patients

News - May 28, 2019

Novel PCSK9 inhibitor yields safe and effective LDL-c lowering

News - May 28, 2019

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension: Key questions addressed

Online-CME - This course consists of 3 separate lectures

Why cardiologists should be more interested in PAH

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA

Novel insights in the management and prognosis of pulmonary hypertension

5' education - Aug. 29, 2017 - ESC 2017, Barcelona, Spain - Prof Nazzareno Galiè - Bologna, Italy

Stroke

No reduction of recurrent stroke with DOAC after embolic stroke of undetermined source

Literature - June 12, 2019 - Diener H-C, et al. - N Engl J Med 2019

High residual inflammatory risk associated with adverse clinical outcomes in patients undergoing PCI with low LDL-c

Literature - June 7, 2019 - Guedeney P et al. - JACC 2019

Uninterrupted treatment with NOAC as alternative to VKA for ablation of AF

Literature - June 5, 2019 - Hohnloser SH et al. - Eur Heart J 2019

© 2006 - 2019 pace-cme.org - About